The Asia region comprises the eastern countries on the Asian continent and the countries and islands in the Pacific Ocean. It is characterized by extreme diversity in size and population of individual countries.
There are also major differences in the types of diseases that affect people in the region, the capacity of each country to respond to health challenges, and the current status and future trends in health and health care. Moreover, some of the countries in this region are prone to severe natural disasters, such as earthquakes and floods, leading to additional health and survival challenges.
NIAID priorities for research in this region include HIV/AIDS, tuberculosis, malaria, and emerging diseases such as avian influenza. NIAID has also funded research related to major endemic diseases such as amebiasis and cholera, filariasis, rotavirus, hepatitis C, and dengue fever.
NIAID continues to explore opportunities with researchers and organizations in this region. Current partnerships include the U.S.-China Collaborative Biomedical Research Program and the U.S.-Japan Cooperative Medical Sciences Program.
- Australia
- Burma (Myanmar)
- Cambodia
- China
- Fiji
- Indonesia
- Japan
- Laos
- Malaysia
- Mongolia
- New Zealand
- Papua New Guinea
- Philippines
- Samoa
- Singapore
- Solomon Islands
- South Korea
- Taiwan
- Thailand
- Vietnam
Highlights
U.S.-Mongolia Workshop on Chronic Viral Hepatitis and Primary Liver Cancer, September 14-16, 2015, Ulaanbaatar, Mongolia
The goals for this workshop included reviewing advances in viral hepatitis, chronic liver disease and liver cancer; discussing the potential for U.S. – Mongolia research collaboration in these areas; and discussing mechanisms for collaboration and training.
E-ASIA 2015 Board Meeting and Scientific Workshop, August 11-14, 2015, Yangon, Burma
The goals of this workshop included sharing knowledge about current research (published and unpublished data) on malaria, tuberculosis, drug-resistant infectious organisms, neglected tropical diseases, and infectious diseases linked to malignancies, such as human papillomavirus, viral hepatitis, and HIV; assessing the infectious disease and cancer research priorities in e-ASIA member countries and among South East Asian scientists, and identifying potential collaborative research partnerships to address the prevention, diagnosis, treatment, and control of high-priority infectious diseases in South East Asia and the Pacific Rim.